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The b2 integrin family (CD11/CD18) of leukocyte adhesion molecules plays a key role in inflammation. Absence
of the common b chain (CD18) leads to leukocyte adhesion deficiency-1 (LAD1) in humans. We here summarize
data of two genetically defined mice models of b2 integrin deficiency, one with a CD18 null mutation (CD18
/),
and the other one with a hypomorphic CD18 mutation (CD18hypo). Firstly, we focus on the underlying
mechanism of a severely impaired wound healing in CD18/ mice, outlining a scenario in which a defective
extravasation and phagocytosis of CD18/ neutrophils results in delayed myofibroblast-dependent wound
contraction owing to a deficient transforming growth factor-b1 release. Based on this, we have identified a
potential therapy that fully rescued the impaired wound healing in CD18/ mice. Secondly, we expand on a
CD18hypo PL/J mouse model closely resembling human psoriasis. Apart from common clinical and
pathophysiological features, this psoriasiform dermatitis also depends on the presence of activated CD4þ
T cells. We here recapitulate the influence of a reduced CD18 gene expression on T-cell function, also with
regard to CD18 gene–dose effects, and its contribution to the pathogenesis of this disease. Taken together, these
unique features make this model a valuable tool for investigations into the pathogenesis of human psoriasis –
including its polygenic base – and future preclinical studies.
Journal of Investigative Dermatology Symposium Proceedings (2006) 11, 7–15. doi:10.1038/sj.jidsymp.5650006
b2 INTEGRINS IN INFLAMMATION
During the last years, the genetic approach for studies on
leukocyte and endothelial cell adhesion molecules has been
successfully implemented (Mayadas et al., 1993; Sligh et al.,
1993; Wilson et al., 1993; Carlos and Harlan, 1994; Bullard
et al., 1995; Coxon et al., 1996; Frenette et al., 1996; Lu
et al., 1997; Jung et al., 1998; Stark et al., 2005). Genetically
defined mice represent models of human diseases, which
allow the functional analysis of genes and of the polygenic
susceptibility for inflammatory disorders such as autoimmune
diseases, arthritis, psoriasis, atopic dermatitis, asthma, and
atherosclerosis (Leiter, 1989; Garchon et al., 1991; Rubin and
Smith, 1994; Shih et al., 1995; Bullard et al., 1996; Lam-Tse
et al., 2002; Olofsson et al., 2003; Laitinen et al., 2004;
Andersson and Holmdahl, 2005; Kere, 2005; Liston and
Goodnow, 2005; Mazon Pelaez et al., 2005). Our group has
a long-standing interest in further defining the role of b2
integrins in complex skin diseases. b2 integrins are leukocyte
adhesion molecules exclusively expressed on hematopoietic
cells being responsible for cell–cell contacts in a variety of
inflammatory interactions, and in particular, they participate
crucially in the extravasation process of leukocytes (Figure 1)
(Arnaout, 1990; Harris et al., 2000). After tethering and
rolling, they play a unique role in firm adhesion and
transmigration through endothelia (Springer and Anderson,
1986). The common b chain (CD18) associates with four a
subunits (aL, aM, aX, and aD) forming distinct functional
heterodimers termed LFA-1 (CD11a/CD18), Mac-1 (CD11b/
CD18), gp150,95 (CD11c/CD18), and CD11d/CD18 (Arna-
out, 1990). These receptors interact with more than 20
ligands, of which the most prominent belong to the family of
intercellular adhesion molecule (Dustin and Springer, 1988;
Staunton et al., 1989; Diamond et al., 1990; Vazeux et al.,
1992; de Fougerolles et al., 1994).
Lack of CD18 leads to leukocyte-adhesion deficiency
type-1 (LAD1), a recessively inherited disorder in which
deletions, truncations, substitutions, or frameshift mutations
impair b2-integrin function (Kishimoto et al., 1987; Arnaout,
1990). The severity of this disease correlates with the degree
of loss of CD18 (Anderson et al., 1985). In the absence of
functional CD18, severe defects in cell–cell cooperation
occur leading to a lack of homotypic lymphocyte adhesion
(Mentzer et al., 1985; Rothlein and Springer, 1986; Koopman
et al., 1992) and hampered T-cell activation (Davignon et al.,
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1981; Bachmann et al., 1997; Scharffetter-Kochanek et al.,
1998; Scho¨nlau et al., 2000) accompanied by a reduced IL-2
release (Shier et al., 1996; Zuckerman et al., 1998; Kim et al.,
1999; Scho¨nlau et al., 2000). Patients suffering from LAD1
are typically subject to recurrent bacterial or fungal infection,
peripheral leukocytosis, impaired wound healing, weak or
absent vaccine response (Fischer et al., 1986; Ochs et al.,
1993; Anderson and Smith, 2001), and, in case of moderate
b2 integrin-expression deficiency, also psoriasiform dermati-
tis (van de Kerkhof and Weemaes, 1990).
In the past years, we have established and/or studied two
genetically defined mice models of b2 integrin deficiency,
following two different mutation strategies for the CD18
locus: (1) Introduction of the neomycin resistance cassette
into the splice acceptor site of exon 3 resulted in an out-of-
frame mutation yielding no functional CD18 protein at all
(Scharffetter-Kochanek et al., 1998). (2) Duplication of exons
2 and 3 by introduction of an insertion mutation in the
murine CD18 gene yielded a hypomorphic mouse model of
CD18 with a severe reduction in CD18 expression with only
2–16% of wild-type (WT) levels of CD18 (Wilson et al., 1993;
Bullard et al., 1996).
WOUND-HEALING DEFECT OF CD18/ MICE OWING
TO A DECREASE IN TGF-b1 AND MYOFIBROBLAST
DIFFERENTIATION
Herein, we will first focus on the underlying mechanism of
severely impaired wound healing in LAD1 (Peters et al.,
2005). For this purpose, we have used the previously
generated full knockout mouse model (CD18/), which
closely reflects the clinical phenotype of patients suffering
from severe-type LAD1 with spontaneously occurring ero-
sions and wounds in mechanically stressed facial areas
(Scharffetter-Kochanek et al., 1998). Firstly, it is of impor-
tance to define precisely the parameter and wound model
(primary versus secondary wound healing, re-epithelializa-
tion versus wound contraction) employed for studies on tissue
and wound repair (Singer and Clark, 1999; Werner and
Grose, 2003). Therefore, to analyze secondary wound
healing under standardized conditions, full-thickness 5-mm
punch biopsies were produced on the back of CD18/ and
WT control mice. Monitoring of wound sizes revealed a
significant delay in wound healing from days 5 to 14 in
CD18/ mice compared to WT mice (Figure 2). As
differences in wound sizes between WT control mice and
CD18/ mice were most pronounced from days 5 to 10
postwounding, which represents the phase of myofibroblast-
mediated wound contraction, expression of myofibroblast
markers was studied in granulation tissue at different stages of
tissue repair by immunohistochemistry and Western blot
analysis. Myofibroblasts are characterized by the expression
of a-smooth muscle actin (a-SMA) (Tomasek et al., 2002), the
actin isoform characteristic of vascular smooth muscle cells
(Skalli et al., 1986; Serini and Gabbiani, 1999), which confers
a high contractile activity to these cells, in vivo (Serini and
Gabbiani, 1999) and in vitro (Arora and McCulloch, 1994;
Hinz et al., 2001, 2003). In CD18/ mice, a-SMA expression
was substantially reduced at days 5 and 7, compared to the
WT controls. Besides, ED-A splice variant of fibronectin,
another myofibroblast differentiation marker (Serini et al.,
1998), was significantly decreased in CD18/ mice as
compared to the WT. Vimentin served as a housekeeping
protein to equilibrate for equal numbers of fibroblastic cells,
and did not differ in CD18/ mice versus WT mice at these
time points. Consequently, the detected reduction in myo-
fibroblast differentiation markers reflected a decrease in the
number of myofibroblastic cells in wounds of CD18/ mice.
Besides, transforming growth factor (TGF)-b signalling
seemed to be involved as TGFbRII protein levels were also
decreased in CD18/ granulation tissue at day 5 after
wounding. Interestingly, TGF-b1 is one major cytokine
inducing a-SMA expression, myofibroblast differentiation
(Desmoulie`re et al., 1993), and subsequent wound contrac-
tion (Montesano and Orci, 1988). This action of TGF-b1
depends on the presence of ED-A fibronectin in the
extracellular matrix (Serini et al., 1998). To assess TGF-b1
Figure 1. Features of b2 integrins. The ab heterodimeric structure is common
to all integrins. The a chain includes seven extracellular N-terminal
homologous repeats organized into a b propeller structure. The a chain I
domain is shown in pink with the embedded metal ion-dependent adhesion
site motif in orange, and the b chain I-like domain with metal ion-dependent
adhesion site motif is shown in a corresponding manner. The GFFKR
sequence in the cytoplasmic tail of the a subunit is involved in heterodimer
assembly and regulation of ligand recognition. The heterodimer is illustrated
in the ‘‘closed’’ or inactive state that undergoes tertiary and quaternary
changes in response to inside-out signals. See ‘‘Structure and distribution,’’
‘‘Ligand Recognition,’’ and ‘‘Inside-out Signaling’’ for details. (This figure was
reproduced from Harris et al. (2000), with permission from The American
Society for Biochemistry and Molecular Biology.)
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cytokine levels in wound tissue of CD18/ mice versus WT
mice, we performed immunohistochemistry for TGF-b1 on
sections of 5- and 7-day-old wounds as well as ELISA
measurements for quantification of active TGF-b1 from
wound tissue lysates. As a result, there was distinctly less
TGF-b1 detectable in the newly formed granulation tissue of
CD18/ mice at both of these time points after wounding, as
compared to the WT controls. These data suggested that
reduced amounts of TGF-b1 had accounted for the decreased
numbers of a-SMA-positive myofibroblasts and the impaired
wound contraction in CD18/ mice.
In order to prove a causal role for the TGF-b1 deficiency in
the reduced wound closure of CD18/ mice, we substituted
the lacking endogenous TGF-b1 by injecting recombinant
human TGF-b1 subcutaneously at four sites around the
wound (Ashcroft et al., 2003). Mock injections were made
using NaCl 0.9%. Gross evaluation and digital measurements
of wound sizes revealed that the previously observed wound
healing defect was fully restored in CD18/ mice treated
with recombinant TGF-b1, a finding further confirmed by the
detection of a-SMA-positive myofibroblasts at wild-type
levels in these mice (Figure 3). These data strongly suggested
that TGF-b1 deficiency was the major cause of an impaired
tissue repair in CD18/ mice. However, the mechanism
underlying this TGF-b1 deficiency needed clarification.
To tackle the question which cells may have contributed
to the observed TGF-b1 deficiency in wounds of CD18
/
mice, one has to consider that normal tissue repair follows a
sequence of events involving clotting, inflammation, remo-
delling, and re-epithelialization (reviewed by: Martin, 1997;
Singer and Clark, 1999). Shortly after injury, first neutrophils
and later macrophages invade the wound site. Although such
inflammatory cells are an important source of growth factors
Figure 2. Wound closure of full-thickness wounds is delayed in CD18/
mice. Full-thickness (including the panniculus carnosus) excisional wounds
were punched at two sites in the middle of the dorsum using 5-mm biopsy
round knives. Each wound region was digitally photographed at indicated
time points, and wounds areas were calculated using Adobe Photoshop
software. (a) Macroscopic observation of wounds in CD18/ and WT mice.
Representative results of six wounds in each cohort are shown. (b) Wound
sizes at any given time point after wounding were expressed as the percentage
of initial (day 0) wound area for CD18/ and WT mice. Results are expressed
as the mean7SD (n¼ 6). * Po0.05. (This figure was reproduced from Peters
et al. (2005), with permission from the Nature Publishing Group.)
Figure 3. Injection of TGF-b1 in wound margins rescues wound closure and
myofibroblast differentiation in CD18/ mice. Recombinant human TGF-b1
(‘‘TGF’’) was injected subcutaneously at four sites around the wound,
allowing to infiltrate the wound margins, at a total dose of 0.45 mg per wound.
Mock injections were made using only the solvent NaCl 0.9%. First,
injections were carried out on day 1 after wounding, followed by further
injections every second day until wounds were harvested. (a) Macroscopic
observation of wounds in CD18/, WT mice with or without injection of
TGF-b1. (b) Wound sizes were assessed at the indicated time points after
wounding as described previously. Bars depict the median of each cohort.
**Po0.005. (c) Paraffin-embedded granulation tissue of CD18/ and WT
mice was stained immunohistochemically for a-SMA 5 days after wounding.
The bar indicates 100 mm; de, adjacent dermis; gt, granulation tissue; arrows
indicate the newly formed epidermal leading edges. (This figure was
reproduced from Peters et al. (2005), with permission from the Nature
Publishing Group.)
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and cytokines (Werner and Grose, 2003), adhesion mole-
cules, and in particular integrins, are required for their
extravasation. We and others have previously shown that in
mouse models for toxic dermatitis and thioglycolate-induced
peritonitis, extravasation of neutrophils depended highly on
b2 integrins (Mizgerd et al., 1997; Scharffetter-Kochanek
et al., 1998; Walzog et al., 1999; Grabbe et al., 2002). To
investigate whether egress of leukocytes from the blood
vessels may, in analogy to dermatitis, be dependent on b2
integrins also during wound healing, we set out to detect
inflammatory cells infiltrating the wound area during the
healing process. In a time-course analysis, wounds were
harvested and stained with GR1 monoclonal antibodies for
neutrophils or with F4/80 for macrophages. Subsequently,
neutrophils and macrophages, which had egressed from the
vessels into the interstitial tissue of the wound bed, were
counted. Almost no neutrophils were detected in the
granulation tissue of CD18/ wounds, compared to high
numbers of egressed neutrophils in WT wounds at 24 and
48 hours. However, similar numbers of egressed macro-
phages were observed at the wound sites of WT and CD18/
mice. These data demonstrated that wounds of CD18/
mice remained almost devoid of neutrophils, whereas
infiltration by macrophages was normal (Peters et al., 2005).
In secondary wound healing, TGF-b1, crucially required
for normal wound closure, is released by macrophages during
the engulfment of apoptotic polymorphonuclear neutrophils
at the wound site (Fadok et al., 1998; McDonald et al., 1999;
Taylor et al., 2000). As we demonstrated, defective migration
leads to a severe reduction of neutrophils in wounds of
CD18/ mice. Hence, we hypothesized that infiltrating
macrophages might not sufficiently phagocytose apoptotic
neutrophils in wounds of CD18/ mice. Macrophages
would thus be lacking their main stimulus to secrete TGF-
b1. Consequently, the effect of phagocytosis of viable and
apoptotic neutrophils by CD18/ and WT macrophages was
studied. We found that only apoptotic but not viable
neutrophils, after being engulfed by macrophages, caused a
dramatic induction in the release of TGF-b1, in line with
earlier reports (Fadok et al., 1998; McDonald et al., 1999). In
this context, it was an astounding finding that CD18/
neutrophils had a higher resistance toward spontaneous
apoptosis, as absent/reduced DNA laddering and annexin-V
staining showed in CD18/ compared to WT neutrophils
(Weinmann et al., 2003). To study whether, apart from the
reduced extravasation of neutrophils into wound beds,
release of TGF-b1 occurring during phagocytosis of neutro-
phils by macrophages may also be dependent on CD18, we
in vitro co-cultured apoptotic CD18/ and WT neutrophils
with CD18/ or WT macrophages. Supernatants were
subjected to ELISA for TGF-b1. As a result, a time-dependent,
up to 20-fold increase in active TGF-b1 release with a
maximum at 24 hours was observed in co-cultures of WT
apoptotic neutrophils and macrophages (Peters et al., 2005).
Interestingly, TGF-b1 release did not exceed control levels
after 24 hours in co-cultures of CD18/ neutrophils with
either WT or CD18/ macrophages. In summary, these data
indicated that a maximal release of TGF-b1 required CD18
expression on both neutrophils and macrophages, but CD18
expression on apoptotic neutrophils in particular seems to be
of great importance for sustained TGF-b1 release by macro-
phages. With regard to the underlying pathophysiological
mechanisms, the observed deficiency in TGF-b1 release in
the absence of CD18 was caused indeed by a reduced
phagocytotic efficacy of macrophages to engulf neutrophils
owing to an impaired adhesion between phagocytotic
effector and target cells (also see van Spriel et al., 2001),
thus attributable mainly to an impaired ‘‘physical attach-
ment’’ in case adhesion molecules were absent (Peters et al.,
2005). Potential contributions of the b2 integrin family to
downstream signalling (Piccardoni et al., 2004) during
phagocytosis are currently being investigated.
In summary, an impaired recruitment of neutrophils into
the wound bed, an enhanced apoptotic resistance of
neutrophils, and a reduced release of TGF-b1 from macro-
phages upon defective engulfment of apoptotic neutrophils
collectively contribute to the observed deficiency of TGF-b1
in CD18/ mice. Hence, CD18 deficiency has multiple
effects on TGF-b1 availability.
As TGF-b1 enhances angiogenesis, we also studied vessel
formation in wound granulation tissues. A decrease in
platelet/endothelial cell adhesion molecule-1 (CD31) expres-
sing blood vessels in CD18/ as compared to WT mice was
observed by immunofluorescence histology of wounds in a
time-course analysis (Schruefer et al., 2006). This difference
in angiogenesis could only be partly rescued by TGF-b1
injection, providing evidence that in addition to the TGF-b1
deficiency, other mechanisms may contribute to the impaired
vessel formation. Because b2 integrins are strongly expressed
on endothelial progenitor cells (EPCs), the role of b2 integrins
for in vivo homing of EPCs in neovascularization was studied
(Chavakis et al., 2005). Firstly, our results showed that b2
integrins mediated the adhesive interactions of EPCs to
mature endothelial cells and to extracellular matrix proteins,
and were critical for chemokine-induced transendothelial
migration of EPCs in vitro. Secondly, using a murine in vivo
hind limb ischemia model, proximal femoral arteries were
ligated and, by consequence, distal tissue nutrition and
regeneration depended on new vessel formation. By transfu-
sion of murine Sca-1þLin hematopoietic progenitor cells
from CD18/ mice, it could be demonstrated that b2
integrins were involved in the homing of hematopoietic
progenitor cells to sites of ischemia and were critical for their
neovascularization capacity. This was shown quantitatively
by assessing the reconstitution of vessel density and
functionally by determining distal blood flow at given time
points after transfusion of EPCs into recipients using color-
encoded Doppler laser analysis. Interestingly, pre-activation
of b2 integrins on the transfused EPC further augmented the in
vivo neovascularization capacity of EPC, indicating a novel
therapeutic strategy to promote homing of EPC (Chavakis
et al., 2005).
In summary, CD18 is central for the emigration of
neutrophils into the wound bed. Murine CD18/ macro-
phages release significantly less TGF-b1 after phagocytosis of
apoptotic neutrophils compared to WT macrophages. This
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reduced release of TGF-b1 is owing to an impaired adhesion
and subsequently impaired phagocytosis of CD18/ neu-
trophils by macrophages. Exclusively apoptotic neutrophils
can induce TGF-b1 release from macrophages, whereas
apoptosis is significantly reduced in CD18/ neutrophils
compared to WT neutrophils, owing to an enhanced bcl-x/
bax-a ratio. All of these mechanisms likely contribute to the
observed TGF-b1 deficiency and defective healing of acute
wounds, which can be widely rescued by the local injection
of recombinant TGF-b1 in CD18
/ mice. In addition, b2
integrins play a non-redundant role for homing and
neovascularization capacity of EPCs.
The herein summarized data thus demonstrates that the
paracrine secretion of growth factors induced by wound-
infiltrating neutrophils is essential for myofibroblast differ-
entiation in tissue repair of cutaneous full-thickness wounds,
implying a therapeutic value for growth factor substitution
during specific wound healing deficiency. Furthermore, the
pre-activation of b2 integrins appears to be a feasible tool to
improve the efficacy of EPC-induced neovascularization,
possibly relevant for patients with ischemic disease and
distinct tissue repair disturbances. Regarding the importance
of b2 integrins in the mobilization and migration of
hematopoietic cells during tissue repair, this endorses an
analogous conception as outlined also for other adhesion
molecules in (a) double P- and E-selectin-deficient mice
(Subramaniam et al., 1997), (b) functionally P- and E-selectin-
deficient mice (mice deficient in b-1,4-galactosyltransferase,
which glycolsylates the P- and E-selectin ligands (Mori et al.,
2004)), and (c) LAD2 patients suffering from a glycosylation
deficiency owing to a gene defect in the GDP-fucose
transporter (Luhn et al., 2001). These all have in common
that affected individuals show an altered emigration of
neutrophils and/or macrophages, combined with an impaired
wound healing. Interestingly, intercellular adhesion mole-
cule-1/ mice lacking one of the multiple counter receptors
of the b2 integrins only reveal a subtle wound-healing defect
(Nagaoka et al., 2000). However, none of these studies have
directly analyzed wound contraction.
THE ROLE OF CD18 IN A MURINE T-CELL-DEPENDENT
PSORIASIS MODEL
Another genetically defined mouse model with a specific
gene defect in the CD18 locus, currently the only available
polygenic mouse model for a psoriasiform skin disease,
helped us to explore the involvement of distinct T-cell
populations in this inflammatory disease. In addition, it will
allow for identification of modifier genes and their interaction
in the precipitation of this disease.
Owing to a hypomorphic CD18 mutation, a skin disease
developed in PL/J mice, which strongly resembled human
psoriasis clinically, histologically, and in response to therapy
(Wilson et al., 1993; Bullard et al., 1996). Affected mice
presented with erythema, crusts, scaling, and alopecia
starting at the face and involving the trunk (Figure 4).
Compared to the two-layered epidermis in WT mice,
epidermal thickening occurred in CD18hypo mice, with
subcorneal micro-abscesses and hyperkeratosis as well as a
severe T-cell-dominated infiltrate in the dermis, all of which
characteristic hallmarks of human psoriasis. Only mice
homozygous for the CD18-hypomorphic (CD18hypo) muta-
tion but not heterozygous littermate controls developed this
phenotype, suggesting that the disease was recessively
inherited. Interestingly, the psoriasiform skin inflammation
only occurred on PL/J mice carrying the CD18hypo mutation
but not on the 129Sv or C57BL/6J genetic background with
the same mutation (Bullard et al., 1996). Hence, apart from
the CD18 mutation, a small number of genes were necessary
to precipitate the phenotype. No infectious agent was
detected, whereas corticosteroids suppressed the psoriasi-
form phenotype, suggesting the involvement of an auto-
immune or otherwise (sterile) inflammatory process.
Figure 4. In vivo depletion of CD4þ T cells in CD18hypo mice. To monitor
the clinical effect of CD4þ T cell depletion, neutralizing antibodies were
injected intraperitaneously at a dose of 100–150 mg twice weekly. (a) A
CD18hypo mouse with a severe psoriasiform dermatitis. (b) The same mouse 6
weeks after treatment with CD4þ T-cell-depleting mAbs. Depletion efficiency
was evaluated by FACS analysis of peripheral blood cells from CD18hypo mice
treated with the (c) isotype control mAbs or with (d) CD4þ T cell-depleting
mAbs. . Mouse anti-rat (MAR) IgG2b FITC mAbs were applied for the
detection of residual rat anti-mCD4 mAbs, which had previously been used
for depletion of CD4þ T cells. The red circle highlights the CD4þ T-cell
population. Skin sections from CD18hypo mice treated with (e) isotype control
mAbs or with (f) CD4þ T-cell-depleting mAbs were immunostained with
mCD4 mAbs (original magnification 400). Arrows indicate the murine
full-thickness epidermis from cornified to basal layer. (This figure was
reproduced from Kess et al. (2003), with permission from The American
Association of Immunologists.)
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The pathogenic role of b2 integrins in human psoriasis is
poorly understood. CD11b expression has been reported to
be reduced on peripheral blood leukocytes derived from
psoriasis patients (van Pelt et al., 1998). Further experimental
evidence comes from LAD1 patients with a moderately
reduced CD18 expression suffering from psoriasiform skin
disease (van de Kerkhof and Weemaes, 1990). Linkage
analyses of psoriasis families identified a region on chromo-
some 17 (Tomfohrde et al., 1994), including among other
gene loci, intercellular adhesion molecule-2, an important
ligand of CD11/CD18 heterodimers. Vice versa, polymorphi-
sms in the CD18 gene were found predisposing to
autoimmune disease either by leading to a higher ligand
affinity or by increasing expression of the CD18 protein
(Gencik et al., 2000; Meller et al., 2001). Different cell types
have been suspected to be the primary inducer in the
pathogenesis of psoriasis (van den Oord and de Wolf-Peeters,
1994; Nickoloff, 1999; Nickoloff and Nestle, 2004; Ozawa
and Aiba, 2004). Increasing evidence led to the current view
that T cells were the main suspects responsible for its
initiation (Nickoloff et al., 2000; Krueger, 2002). Therefore,
we first studied different T-cell subpopulations in the skin of
CD18hypo psoriasis mice (Kess et al., 2003). Compared to WT
mice, a significant increase in CD4þ T cells was found in the
epidermis and the dermis of CD18hypo mice compared to WT
mice. Most interestingly, effective depletion of CD4þ T cells,
as proven by FACS analysis, revealed a complete resolution
of the psoriasiform skin disease within 6 weeks of treatment
(Figure 4). The effect of the CD4þ T-cell-depleting mono-
clonal antibodies was evaluated by the severity of clinical
symptoms using an adapted murine psoriasis area and
severity index (PASI) score (Kess et al., 2003), as commonly
used for the assessment of severity in human psoriasis. A
complete resolution of the psoriasiform skin disease was
observed in two mice (PASI 10 down to 1) and an almost
complete resolution in one mouse (PASI 8 down to 2) treated
with the anti-CD4 monoclonal antibodies. This clearance of
the skin inflammation persisted for an observation period of 6
months after the last administration of depleting antibody,
whereas for three further CD18hypo mice mock-treated with
IgG isotype antibodies, no significant changes in the PASI
scores were evident. As CD4þ T cells can exert their effects
via activation of cytotoxic effector functions of CD8þ T cells,
CD18hypo mice were also treated with CD8þ T-cell-depleting
mAb in an analogous experimental setting (Kess et al.,
2003). As monitored by the adapted PASI score, treatment
with neither CD8þ T-cell-depleting monoclonal antibodies
nor isotype-matched control antibodies resulted in any
improvement of the psoriasiform skin disease. These results
suggested that CD8þ T cells were not crucial for the
pathogenesis of the inflammatory skin disease of this
psoriasis-like mouse model. However, apart from CD4þ
T cells, a distinct role in the pathogenesis of this skin
disease was also attributed to CD8þ T cells by other
investigators (Barlow et al., 2004), possibly on the basis of
a slightly different segregation of genes during the main-
tenance/backcrossing of the respective mouse strain (Barlow
et al., 2003).
To determine the activation state of T cells in affected
mice, CD90þ T cells were isolated from draining lymph
nodes of diseased CD18hypo and healthy WT mice (Kess
et al., 2003). A significant increase in the expression of CD25
(IL-2Ra chain) as a measure of T cellular activation was
detected on CD4þ but not on CD8þ T cells obtained from
diseased CD18hypo mice. Because the mean expression of
CD25 on CD4þ T cells was twice as high in CD18hypo as in
WT mice, this suggested an increased state of activation in
CD4þ T cells from CD18hypo mice. To further determine
whether T cells obtained from draining lymph nodes had
been primed to secrete either Th1- or Th2-type cytokines, we
measured the release of IFN-g or IL-4 after culturing with
different concentrations of immobilized anti-CD3 and anti-
CD28 monoclonal antibodies. CD90þ T cells from affected
CD18hypo mice released up to 40-fold higher amounts of IFN-
g compared to WT mice, whereas no IL-4 could be detected
in the supernatants of activated T cells of either genotype.
These data pointing at a prevalence of Th1-type cytokines in
CD18hypo mice was supported by studies using an extended
Th1/Th2 panel for cytometric bead array detection of
cytokines (Kess et al., 2003). Apart from IFN-g, very high
levels of the Th1 key cytokine IL-2 were also detected in the
supernatants of CD18hypo T cells. However, the Th2 cytokine
IL-10 was slightly increased. Still, these data clearly demon-
strated the prevalence of Th1 cytokines in T cells isolated
from the skin lesion draining lymph nodes of CD18hypo mice.
To address the question whether total absence of CD18
may equally lead to the development of a psoriasiform
phenotype in mice of the PL/J strain, a PL/J mouse line with a
complete deficiency in CD18 (CD18/) was generated (Kess
et al., 2003). Remarkably, during an observation period of
more than 2 years, PL/J CD18/ mutants (n¼ 200) did not
develop any psoriasiform skin disease. Consequently, we
hypothesized that the T cells required for the psoriasiform
dermatitis of CD18hypo mice may not be able to enter the skin
in complete absence of CD18 adhesion molecules, thus
being hampered to exert their inflammatory effector func-
tions. As antigen-specific T cells are most likely to play a
central role in the pathogenesis of psoriasis, but the
responsible antigen could so far not be identified, it is
difficult to study the emigration kinetics of antigen-specific T
cells. Therefore, we used a model of T-cell-mediated type-IV
hypersensitivity, allowing the induction of an allergic contact
dermatitis under standardized conditions with oxazolone as a
defined antigen (Kess et al., 2003). To differentiate clearly
between the deliberately induced allergic contact dermatitis
and the spontaneously developing psoriasiform skin inflam-
mation in CD18hypo PL/J mice, we only analyzed clinically
healthy CD18hypo mice, comparing these mice with equally
treated CD18/ and WT mice as controls. As a result,
allergic contact dermatitis could only be induced in
CD18hypo and WT mice but not in CD18/ mice upon
repeated oxazolone challenge. As hematoxylin and eosin and
immunostainings of sections from oxazolone-challenged ears
revealed, this was owing to a failure of CD18/ T cells, both
CD4þ and CD8þ , to emigrate from the vessels into the
tissue, thus causally contributing to the unresponsiveness of
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CD18/ mutants to oxazolone. Interestingly, T cells isolated
from the draining lymph nodes of sensitized CD18/ mice
could rescue the ear swelling phenotype in response to
oxazolone challenge when directly injected in the ears of
CD18/ mice before the re-challenge with oxazolone,
suggesting that CD18 was not absolutely required for priming
of naı¨ve T cells but was indispensable for T-cell extravasation
(Grabbe et al., 2002). Hence, 2–16% of CD18 gene
expression proved to be sufficient for oxazolone-specific T
cells to emigrate from blood vessels during allergic contact
dermatitis (Kess et al., 2003). Given that in psoriasis vulgaris
specific T cells are most likely directed against an, to date,
undefined epidermal antigen, our finding that T cells cannot
efficiently extravasate into the skin in CD18/ mutants may
explain the absence of a psoriasiform phenotype in these
mice. These findings support the conclusion that the
pathogenic involvement of CD4þ T cells in the skin disorder
of the CD18hypo PL/J mice depends on a gene-dose effect of
CD18 expression.
C57BL/6 or 129Sv mice with the identical CD18hypo
mutation leading to the psoriasiform dermatitis in PL/J mice
do not develop an inflammatory skin disease (Bullard et al.,
1996; Barlow et al., 2003; Kess et al., 2003). These data
indicate that apart from the CD18hypo mutation, other gene
loci are responsible for the development and the onset of this
inflammatory skin disease. In order to further identify
involved chromosome fragments, backcross analysis between
the susceptible PL/J strain and the resistant C57BL/6 strain
was performed. This cross resulted in an F1 generation with
no obvious phenotype. When crossing back mice of the F1
generation to the susceptible CD18hypo PL/J mice, 30% of the
resulting N2 generation revealed a psoriasiform phenotype,
suggesting that apart from the CD18hypo mutation other
modifier genes were required for the development of this
phenotype (Bullard et al., 1996; Barlow et al., 2003). In order
to analyze the critical chromosome fragments of the two
mouse strains involved in the precipitation of the phenotype,
a genome-wide microsatellite analysis was performed from
genomic DNA of the N2 backcross generation. Collectively,
the assessment of the LOD scores for the linkage of specific
chromosome regions with the disease revealed that, in
addition to the CD18 mutation, two genes were found to
determine the susceptibility and four or more genes
determine the severity of the psoriasiform dermatitis in
CD18hypo PL/J mice. Most prominent linkage (LOD score
45) was found for gene loci on chromosome 10, revealing a
strong linkage for the incidence of the psoriasiform derma-
titis, and on chromosome 6 for the time point of onset of the
disease. In addition, female mice were observed to be more
susceptible for the psoriasiform skin inflammation than male
mice (data submitted for publication). Currently, the genera-
tion of congenic strains and positional cloning is now
underway to finally identify the genes involved in the
psoriasiform skin disease and their potential interaction with
CD18.
The herein summarized data on the role of b2 integrins
in a murine model of psoriasis in CD18hypo PL/J mice may
further support the conception of T cell-dependent skin
inflammation and have relevance also for the understanding
of polygenic human inflammatory skin diseases.
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